PL1888748T3 - Stabilne i selektywne tworzenie tripleksów i dupleksów typu hoogsteen przy zastosowaniu skręconych interkalujących kwasów nukleinowych (tina) i proces wytwarzania tina - Google Patents

Stabilne i selektywne tworzenie tripleksów i dupleksów typu hoogsteen przy zastosowaniu skręconych interkalujących kwasów nukleinowych (tina) i proces wytwarzania tina

Info

Publication number
PL1888748T3
PL1888748T3 PL06753367T PL06753367T PL1888748T3 PL 1888748 T3 PL1888748 T3 PL 1888748T3 PL 06753367 T PL06753367 T PL 06753367T PL 06753367 T PL06753367 T PL 06753367T PL 1888748 T3 PL1888748 T3 PL 1888748T3
Authority
PL
Poland
Prior art keywords
tina
hoogsteen
duplexes
stable
preparation
Prior art date
Application number
PL06753367T
Other languages
English (en)
Inventor
Vyachelsav V Filichev
Erik Bjerregaard Pedersen
Original Assignee
Tina Holding Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tina Holding Aps filed Critical Tina Holding Aps
Publication of PL1888748T3 publication Critical patent/PL1888748T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/332—Abasic residue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3511—Conjugate intercalating or cleaving agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL06753367T 2005-05-25 2006-05-24 Stabilne i selektywne tworzenie tripleksów i dupleksów typu hoogsteen przy zastosowaniu skręconych interkalujących kwasów nukleinowych (tina) i proces wytwarzania tina PL1888748T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200500762 2005-05-25
PCT/DK2006/050022 WO2006125447A2 (en) 2005-05-25 2006-05-24 Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina
EP06753367.9A EP1888748B1 (en) 2005-05-25 2006-05-24 Stable and selective formation of hoogsteen-type triplexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina

Publications (1)

Publication Number Publication Date
PL1888748T3 true PL1888748T3 (pl) 2014-03-31

Family

ID=36954326

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06753367T PL1888748T3 (pl) 2005-05-25 2006-05-24 Stabilne i selektywne tworzenie tripleksów i dupleksów typu hoogsteen przy zastosowaniu skręconych interkalujących kwasów nukleinowych (tina) i proces wytwarzania tina

Country Status (16)

Country Link
US (1) US9102937B2 (pl)
EP (1) EP1888748B1 (pl)
JP (1) JP5284084B2 (pl)
CN (1) CN101238213B (pl)
AU (1) AU2006251496B2 (pl)
BR (1) BRPI0611514A2 (pl)
CA (1) CA2609365C (pl)
DK (1) DK1888748T3 (pl)
ES (1) ES2436760T3 (pl)
NZ (1) NZ564146A (pl)
PL (1) PL1888748T3 (pl)
PT (1) PT1888748E (pl)
RU (1) RU2487164C2 (pl)
SI (1) SI1888748T1 (pl)
WO (1) WO2006125447A2 (pl)
ZA (1) ZA200710160B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101289164B1 (ko) * 2008-03-10 2013-07-31 퀜티백트 에이/에스 삼중나선구조 형성 단량체 단위를 포함하는 프라이머를 이용한 표적증폭 및 서열분석
US20110130557A1 (en) 2008-05-07 2011-06-02 Erik Bjerregaard Pedersen Intercalating triplexes and duplexes using aryl naphthoimidazol and process for the preparation thereof
RU2389536C1 (ru) * 2008-11-20 2010-05-20 Станислав Викторович Хартов Активное молекулярное сито
JP2013524841A (ja) * 2010-05-07 2013-06-20 クアンティバクト エー／エス 一本鎖オーバーハングを有する二本鎖核酸を生成するための方法
EP2407552B1 (en) * 2010-07-13 2012-11-14 Cnrs Method for the isolation of the proteins bound to any kind of interesting nucleic acid sequence
JP2014512175A (ja) 2011-03-28 2014-05-22 クアンチバクト エー／エス 積層核酸及びそれを使用するための方法
US10858650B2 (en) 2014-10-30 2020-12-08 The General Hospital Corporation Methods for modulating ATRX-dependent gene repression
JP2018500932A (ja) 2014-12-22 2018-01-18 アナーパ バイオテック エー／エス 標的核酸のマルチプレックス検出のためのデュアルクエンチングアッセイ
EP3484908A4 (en) 2016-07-15 2020-04-08 AM Chemicals Llc NON-NUCLEOSIDIC SOLID CARRIERS AND PHOSPHORAMIDITE BUILDING BLOCKS FOR OLIGONUCLEOTID SYNTHESIS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4547569A (en) * 1982-11-24 1985-10-15 The United States Of America As Represented By The Department Of Health And Human Services Intercalating agents specifying nucleotides
US6358931B1 (en) * 1990-01-11 2002-03-19 Isis Pharmaceuticals, Inc. Compositions and methods for modulating RNA
CA2197117A1 (en) 1994-08-10 1996-02-22 Sidney Altman Antisense and triplex therapeutic agents and methods
US5681940A (en) * 1994-11-02 1997-10-28 Icn Pharmaceuticals Sugar modified nucleosides and oligonucleotides
CA2303299C (en) * 1997-09-12 2016-02-23 Exiqon A/S Oligonucleotide analogues
EP1161439B1 (en) * 1999-03-18 2010-04-21 Exiqon A/S Xylo-lna analogues
WO2003052134A2 (en) * 2001-12-18 2003-06-26 Human Genetic Signatures Pty Ltd Oligonucleotides comprising intercalator pseudonucleotide(s) for detection of nucleic acids and mutants hereof
WO2005083084A1 (en) 2004-02-25 2005-09-09 Syddansk Universitet Intercalating triplex forming oligonucleotide derivatives and process for the preparation thereof

Also Published As

Publication number Publication date
CA2609365C (en) 2015-04-28
JP2008541708A (ja) 2008-11-27
RU2007145989A (ru) 2009-06-27
RU2487164C2 (ru) 2013-07-10
BRPI0611514A2 (pt) 2010-09-14
AU2006251496A1 (en) 2006-11-30
SI1888748T1 (sl) 2014-02-28
AU2006251496B2 (en) 2012-11-22
US9102937B2 (en) 2015-08-11
CN101238213A (zh) 2008-08-06
EP1888748A2 (en) 2008-02-20
EP1888748B1 (en) 2013-08-28
JP5284084B2 (ja) 2013-09-11
NZ564146A (en) 2011-02-25
CA2609365A1 (en) 2006-11-30
US20090216003A1 (en) 2009-08-27
WO2006125447A2 (en) 2006-11-30
DK1888748T3 (da) 2013-11-18
PT1888748E (pt) 2013-12-02
WO2006125447A3 (en) 2007-01-11
ES2436760T3 (es) 2014-01-07
ZA200710160B (en) 2013-04-24
CN101238213B (zh) 2015-05-20

Similar Documents

Publication Publication Date Title
ZA200710160B (en) Stable and selective formation of hoogsteen-type tripexes and duplexes using twisted intercalating nucleic acids (tina) and process for the preparation of tina
GB2398301B (en) Methods and means for nucleic acid sequencing
AU2003295387A8 (en) Modified oligonucleotides for use in rna interference
EP1668024A4 (en) OLIGONUCLEOTIDE COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES INCLUDING INFLAMMATORY SUFFERING
EP1941050A4 (en) METHODS AND COMPOSITIONS FOR PRODUCING SINGLE-SEQUENCE DNA PROBES, DNA-PROBE LABELING AND USE THEREOF
IL166654A0 (en) Platinum aggregates and process for producing the same
EP1472373A4 (en) PROCESSES FOR THE PRODUCTION AND PURIFICATION OF DOUBLE STRANDED POLYNUCLEOTIDES
EP1731525A4 (en) NUCLEOTIDE DERIVATIVES AND DNA CHIP
EP1633871A4 (en) DOUBLE-STRUCTURED NUCLEIC ACID
NO20055726D0 (no) Fiskeoljer med endret fettsyreprofil, fremgangsmate for fremstilling av samme og deres anvendelse
IL189309A0 (en) Process for producing fullerene dispersion liquid, and fullerene dispersion liquid
ZA200605593B (en) Process for the production of compositions containing ribonucleotides and their use as flavouring agents
EP1334168A4 (en) EXTENSION OF THE CATALYST CYCLE IN REMAINING PURIFICATION
AU2003220115A8 (en) Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone, and other tissues
EP1731903A4 (en) POROUS ELECTRODE AND METHOD FOR THE PRODUCTION THEREOF
AU2003260945A8 (en) Methods of use for thermostable rna ligases
AU2003303588A1 (en) Methods and compositions for sequencing nucleic acid molecules
IL161039A0 (en) Mupirocin compositions for topical use, and improved process of making same and methods of using same
IL178064A0 (en) Chemical process and new crystalline form
GB2435182B (en) Improvements in and relating to the DNA consideration process
PL1663997T3 (pl) 1H-azolilo-metylo-amidy, sposoby ich wytwarzania i ich zastosowanie jako inhibitorów nitryfikacji
ZA200802937B (en) Multicomponent nucleic acid enzymes and methods for their use
GB0317257D0 (en) Improved detergent bar and process for manufacture
EP1614750A4 (en) NOVEL FUNCTIONAL PEPTIDE NUCLEIC ACID AND PROCESS FOR PRODUCING THE SAME
GB2425534B (en) Nucleic Acid Complex And Method Of Introducing Nucleic Acid into Cell Using The Same